Evaluation of risk factors for the development of nephropathy in patients with IDDM: Insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control

Diabetologia

Volumn 40, Issue 3, 1997, Pages 327-331

  Barnas, U ^a   Schmidt, A ^a   Illievich, A ^a   Kiener, H P ^a   Rabensteiner, D ^c   Kaider, A ^b   Prager, R ^a   Abrahamian, H ^c   Irsigler, K ^c   Mayer, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Hosp L Boltzmann Res Inst M   (Austria)

Author keywords

ACE polymorphism; Diabetic nephropathy; Glycaemic control; Hypertension; Risk factors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEQUENCE DELETION; TIME FACTORS;

EID: 8044257708     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050682     Document Type: Article

References (22)

1. Krolewski AS, Warram JH, Rand LI, Kahn CR (1987) Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 317: 1390-1398
2. Hostetter TH (1994) Mechanisms of diabetic nephropathy. Am J Kid Dis 23: 188-192
3. Marre M, Leblanc H, Suarez L, Guyenne TT, Ménard J, Passa P (1987) Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. BMJ 294: 1448-1452
4. Barnas U, Mayer G (1995) Nephroprotektion durch Hemmung des Renin Angiotensin-Systems - Wunsch oder Wirklichkeit? Wien Klin Wochenschr 107: 10-14
5. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M (1993) Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. BMJ 306: 175-182
6. Weidmann P, Boehlen LM, de Courten M (1993) Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 8: 582-584
7. Rigat B, Hubert C, Ahlenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
8. Tiret L, Rigat B, Visvikis S et al. (1992) Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205
9. Cambien F, Costerrousse O, Tiret L et al. (1994) Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90: 669-676
10. Marre M, Bernadet P, Gallois Yet al. (1994) Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388
11. Tarnow L, Cambien F, Rossing P et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494
12. Schmidt S, Schöne N, Ritz E and the diabetic nephropathy study group (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47: 1176-1181
13. Schmidt A, Kiener HP, Barnas U et al. (1996) Angiotensin converting enzyme polymorphism in patients with terminal renal failure. J Am Soc Nephrol 7: 314-317
14. Lindpaintner K, Pfeffer MA, Kreutz R et al. (1995) A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332: 706-711
15. Mogensen CE, Christensen CK, Vittinghus E (1983) The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 32 [Suppl 2]: 64-78
16. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH (1995) Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332: 1251-1255
17. Schunkert H, Hense HW, Holmer SR et al. (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330: 1634-1638
18. Cambien F, Poirier O, Lecerf L et al. (1992) Deletion polymorphism in the gene for the angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641-644
19. Barley J, Blackwood A, Carter ND et al. (1994) Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 12: 955-957
20. Bognetti E, Meschi F, Rota M, Cofano D, Palermo A, Chiumello G (1994) Cardiovascular and hormonal responses to cold pressure test in insulin dependent adolescents with microalbuminuria. J Diabetes Complications 8: 84-88
21. Beretta-Piccoli C, Elshater-Zanetti F, Shaw S, Cusi D, Weidmann P (1994) Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects. Clin Sci Colch 86: 383-390
22. Hsueh WA, Anderson PW (1993) Systemic hypertension and the renin-angiotensin system in diabetic vascular complications. Am J Cardiol 72: 14H-21H